| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LIPOCINE INC NEW | 142,100 | 867,000 | 0.46% | ||
| 2 | Alexza Pharmaceuticals Inc | 247,812 | 1,133,000 | 0.61% | ||
| 3 | ZS PHARMA INC | 100,000 | 2,875,000 | 1.54% | ||
| 4 | THERAPEUTICSMD INC | 846,500 | 3,742,000 | 2.00% | ||
| 5 | NEUROCRINE BIOSCIE COM USD0.001 | 303,503 | 4,502,000 | 2.41% | ||
| 6 | OHR PHARMACEUTICAL INC | 477,000 | 4,536,000 | 2.42% | ||
| 7 | OCERA THERAPEUTICS INC | 703,730 | 5,376,000 | 2.87% | ||
| 8 | RADIUS HEALTH INC | 525,000 | 6,825,000 | 3.65% | ||
| 9 | FLAMEL TECHNOLOGIES SA SPONSORED ADR | 500,000 | 7,500,000 | 4.01% | ||
| 10 | ZAFGEN INC COM | 541,480 | 10,710,000 | 5.72% | ||
| 11 | KERYX BIOPHARMACEUTICALS INCORPORATED | 700,273 | 10,770,000 | 5.76% | ||
| 12 | DBV Technologies | 480,000 | 12,451,000 | 6.65% | ||
| 13 | HERON THERAPEUTICS INC COM | 1,095,734 | 13,499,000 | 7.21% | ||
| 14 | DYAX CORP COM CVR | 2,000,859 | 19,208,000 | 10.27% | ||
| 15 | BIOCRYST PHARMACEUTICALS | 1,744,356 | 22,241,000 | 11.89% | ||
| 16 | Anacor Pharmaceuticals Inc | 1,545,999 | 27,411,000 | 14.65% | ||
| 17 | GW PHARMACEUTICALS PLC | 311,853 | 33,459,000 | 17.88% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-14-008686, filed 2014.08.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
